Medicine guide
Viekirax
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Ombitasvir;paritaprevir;ritonavir
- Made by
- AbbVie Deutschland GmbH & Co. KG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Viekirax is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults. For hepatitis C virus (HCV) genotype specific activity.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
Details
| Made by | AbbVie Deutschland GmbH & Co. KG |
|---|---|
| Active substance | Ombitasvir;paritaprevir;ritonavir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AP53 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2015-01-14 |
| Last updated by the regulator | 2024-10-02 |
| EMA product number | EMEA/H/C/003839 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).